Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke

Life Sci. 2017 Jun 15:179:15-22. doi: 10.1016/j.lfs.2016.11.029. Epub 2016 Dec 2.

Abstract

Aims: The therapeutic potential of nerve growth factor (NGF) against the neurological disorders may be negatively affected by its short half-life. Based on the superior properties of carbon nanotubes (CNTs) for controlled drug delivery, we aimed to prepare CNT-NGF complex and evaluate its effect in an in vitro model of ischemic stroke.

Materials and methods: Multi-walled CNTs (MWCNTs)-NGF complex was prepared using amino-functionalized COOH-MWCNTs and characterized by Fourier transform infrared spectroscopy and transmission electron microscopy. PC12 cells in the absence or presence of NGF (0.5, 1, 2μg/ml), acid- or amine-modified MWCNTs, or MWCNTs-NGF complex (2, 4, 8μg/ml) were exposed to 1 and 6h oxygen-glucose deprivation (OGD) followed by 24h re-oxygenation. Cytotoxicity and oxidative stress were evaluated.

Key findings: OGD significantly reduced the cell viability (P<0.001). NGF dose-dependently increased the cell viability only after 1-h OGD (P<0.05), while, MWCNTs-NGF complex was effective at both 1- and 6-h OGD (P<0.05, P<0.001). NGF reduced the formation of condensed nuclei due to 1-h OGD (P<0.01, P<0.001), while, MWCNTs-NGF showed efficiency at both time points (P<0.05, P<0.01, P<0.001). OGD significantly increased malondialdehyde (MDA) content and decreased catalase (CAT) and superoxide dismutase (SOD) activities (P<0.001). After 1-h OGD, NGF reduced MDA (P<0.001) and increased CAT (P<0.05, P<0.01) and SOD (P<0.01), while, MWCNTs-NGF was effective after both 1- and 6-h OGD (MDA: P<0.01, P<0.001, CAT: P<0.001, SOD: P<0.01, P<0.001).

Significance: Aminated MWCNTs-NGF complex by providing longer lasting effects for NGF might be of therapeutic significance against the disorders associated with NGF deficiency.

Keywords: Carbon nanotubes; Ischemic stroke; NGF; Oxidative stress.

MeSH terms

  • Animals
  • Brain Ischemia / prevention & control*
  • Catalase / metabolism
  • Cell Survival / drug effects
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Glucose / metabolism
  • Malondialdehyde / metabolism
  • Microscopy, Electron, Transmission
  • Nanotubes, Carbon*
  • Nerve Growth Factor / administration & dosage*
  • Nerve Growth Factor / pharmacology
  • Oxidative Stress / drug effects*
  • Oxygen / metabolism
  • PC12 Cells
  • Rats
  • Spectroscopy, Fourier Transform Infrared
  • Stroke / prevention & control*
  • Superoxide Dismutase / metabolism
  • Time Factors

Substances

  • Nanotubes, Carbon
  • Malondialdehyde
  • Nerve Growth Factor
  • Catalase
  • Superoxide Dismutase
  • Glucose
  • Oxygen